Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
20.59
+0.10 (0.49%)
Dec 20, 2024, 4:00 PM EST - Market closed
KNSA Market Cap
KNSA has a market cap or net worth of $1.49 billion as of December 20, 2024. Its market cap has increased by 18.74% in one year.
Market Cap
1.49B
Enterprise Value
1.27B
1-Year Change
18.74%
Ranking
Category
Stock Price
$20.59
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $1.49B, an increase of 57.63%. That is a compound annual growth rate of 7.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCryst Pharmaceuticals | 1.53B |
| Evotec SE | 1.53B |
| Travere Therapeutics | 1.51B |
| Indivior | 1.51B |
| Viridian Therapeutics | 1.48B |
| AtriCure | 1.47B |
| InMode | 1.45B |
| Immunocore Holdings | 1.42B |